MDL Updates

Ozempic and GLP-1 Injury Claims Overview

2025-01-30 · 6 min

The GLP-1 RA MDL consolidates claims alleging severe gastrointestinal injuries from medications including Ozempic, Wegovy, and Mounjaro. Eligibility criteria continue to develop through court proceedings.

Consult a physician for medical concerns. For legal evaluation, participating attorneys review pharmacy records, hospitalizations, and prescribing history.

Attorney Advertising. This article is for educational purposes only and does not constitute legal advice.

Free Case Review